These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 11391544

  • 1. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
    Urbani S, Uggeri J, Matsuura Y, Miyamura T, Penna A, Boni C, Ferrari C.
    Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
    [Abstract] [Full Text] [Related]

  • 2. Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.
    Thammanichanond D, Moneer S, Yotnda P, Aitken C, Earnest-Silveira L, Jackson D, Hellard M, McCluskey J, Torresi J, Bharadwaj M.
    Clin Immunol; 2008 Sep; 128(3):329-39. PubMed ID: 18524682
    [Abstract] [Full Text] [Related]

  • 3. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.
    Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JY.
    J Immunol; 1997 Feb 01; 158(3):1473-81. PubMed ID: 9013994
    [Abstract] [Full Text] [Related]

  • 4. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P, Parroche P, Chatel L, Barretto C, Beck A, Trépo C, Bain C, Lone YC, Inchauspé G, Fournillier A.
    J Med Virol; 2004 Nov 01; 74(3):397-405. PubMed ID: 15368525
    [Abstract] [Full Text] [Related]

  • 5. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH, Feinstone SM, Berzofsky JA.
    J Immunol; 1995 Mar 15; 154(6):2733-42. PubMed ID: 7533182
    [Abstract] [Full Text] [Related]

  • 6. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, Chisari FV, Sette A.
    J Immunol; 1999 Jan 15; 162(2):1156-64. PubMed ID: 9916747
    [Abstract] [Full Text] [Related]

  • 7. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX, He XS, Berenguer M, Cheung RC, González-Candelas F, Wright TL, Greenberg HB.
    J Med Virol; 2004 Apr 15; 72(4):575-85. PubMed ID: 14981760
    [Abstract] [Full Text] [Related]

  • 8. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J, Ahlén G, Kaul A, Frelin L, Alheim M, Barnfield C, Liljeström P, Weiland O, Milich DR, Bartenschlager R, Sällberg M.
    Gut; 2006 Feb 15; 55(2):266-74. PubMed ID: 16105887
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.
    Erickson AL, Houghton M, Choo QL, Weiner AJ, Ralston R, Muchmore E, Walker CM.
    J Immunol; 1993 Oct 15; 151(8):4189-99. PubMed ID: 7691940
    [Abstract] [Full Text] [Related]

  • 10. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid.
    Kamei A, Tamaki S, Taniyama H, Takamura S, Nishimura Y, Kagawa Y, Uno-Furuta S, Kaito M, Kim G, Toda M, Matsuura Y, Miyamura T, Adachi Y, Yasutomi Y.
    Virology; 2000 Jul 20; 273(1):120-6. PubMed ID: 10891414
    [Abstract] [Full Text] [Related]

  • 11. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.
    Lamonaca V, Missale G, Urbani S, Pilli M, Boni C, Mori C, Sette A, Massari M, Southwood S, Bertoni R, Valli A, Fiaccadori F, Ferrari C.
    Hepatology; 1999 Oct 20; 30(4):1088-98. PubMed ID: 10498664
    [Abstract] [Full Text] [Related]

  • 12. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis.
    Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD.
    J Immunol; 1992 Nov 15; 149(10):3339-44. PubMed ID: 1385523
    [Abstract] [Full Text] [Related]

  • 13. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
    Gerlach JT, Ulsenheimer A, Grüner NH, Jung MC, Schraut W, Schirren CA, Heeg M, Scholz S, Witter K, Zahn R, Vogler A, Zachoval R, Pape GR, Diepolder HM.
    J Virol; 2005 Oct 15; 79(19):12425-33. PubMed ID: 16160170
    [Abstract] [Full Text] [Related]

  • 14. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus.
    Bruña-Romero O, Lasarte JJ, Wilkinson G, Grace K, Clarke B, Borrás-Cuesta F, Prieto J.
    Hepatology; 1997 Feb 15; 25(2):470-7. PubMed ID: 9021966
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.
    Leroux-Roels G, Esquivel CA, DeLeys R, Stuyver L, Elewaut A, Philippé J, Desombere I, Paradijs J, Maertens G.
    Hepatology; 1996 Jan 15; 23(1):8-16. PubMed ID: 8550052
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
    Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, Fowler P, Houghton M, Chisari FV.
    J Clin Invest; 1995 Feb 15; 95(2):521-30. PubMed ID: 7860734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.